CD19 and neoplasm: Remarkably, the decrease in expression of PD-1, LAG-3, and TIM-3 in ITK-KO CD19-CAR-T cells, compared with nt-KO CD19-CAR-T cells, remained significant after multiple rounds of exposure to the targeted tumor cells (Figure 4E).